Gene-Environment Interactions in Geriatric Depression

Psychiatric Clinics of North America

Volumn 34, Issue 2, 2011, Pages 357-376

  Lotrich, Francis E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Depression; Elderly; Geriatric; Polymorphism; Stress

Indexed keywords

APOLIPOPROTEIN E4; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE;

EARLY LIFE STRESS; ENVIRONMENTAL FACTOR; ENVIRONMENTAL STRESS; EPIGENETICS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GERONTOPSYCHIATRY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MENTAL STRESS; MONOAMINERGIC SYSTEM; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

AGED; AGING; DEPRESSIVE DISORDER, MAJOR; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIFE CHANGE EVENTS; POLYMORPHISM, GENETIC; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SOCIAL ENVIRONMENT; STRESS, PSYCHOLOGICAL;

EID: 79955406230     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2011.02.003     Document Type: Review

References (162)

1. Murphy-Eberenz K., Zandi P.P., March D., et al. Is perinatal depression familial?. J Affect Disord 2006, 90(1):49-55.
2. Bromberger J.T., Schott L.L., Kravitz H.M., et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry 2010, 67(6):598-607.
3. Panicker V., Evans J., Bjoro T., et al. A paradoxical difference in relationship between anxiety, depression and thyroid function in subjects on and not on T4: findings from the HUNT study. Clin Endocrinol 2009, 71(4):574-580.
4. Mendlewicz J. Disruption of the circadian timing systems: molecular mechanisms in mood disorders. CNS Drugs 2009, 23(Suppl 2):15-26.
5. Buysse D.J. Insomnia, depression and aging. Assessing sleep and mood interactions in older adults. Geriatrics 2004, 59(2):47-51.
6. Kosten T.R., Markou A., Koob G.F. Depression and stimulant dependence: neurobiology and pharmacotherapy. J Nerv Ment Dis 1998, 186(12):737-745.
7. Forster A., Young J. Specialist nurse support for patients with stroke in the community: a randomized controlled trial. BMJ 1996, 312:1642-1646.
8. Narushima K., Kosier T.J., Robinson R.G. Preventing poststroke depression: a 12-week double blind randomized treatment trial and 21-month follow-up. J Nerv Ment Dis 2002, 190:296-303.
9. Rasmussen B.B., Lunde M., Loldrup P.D., et al. A double-blind placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 2003, 44:216-221.
10. Smits F., Smits N., Schoevers R., et al. An epidemiological approach to depression prevention in old age. Am J Geriatr Psychiatry 2008, 16(6):444-453.
11. Raison C.L., Borisov A.S., Majer M., et al. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry 2009, 65(4):296-303.
12. Brodaty H., Green A.A., Koschera A. Meta-analysis of psychosocial interventions for caregivers of people with dementia. J Am Geriatr Soc 2003, 51:657-664.
13. Vinkers D.J., Gussekloo J., Stek M.L., et al. The 15-item geriatric depression scale (GDS-15) detects changes in depressive symptoms after a major negative life event. The Leiden 85-plus Study. Int J Geriatr Psychiatry 2004, 19(1):80-84.
14. Cole M.G. Evidence-based review of risk factors for geriatric depression and brief preventative interventions. Psychiatr Clin North Am 2005, 28:785-803.
15. Lenze E.J., Munin M.C., Ferrell R.E., et al. Association of the serotonin transporter gene-linked polymorphic region (5-HTTLPR) genotype with depressive symptoms in elderly persons after hip fracture. Am J Geriatr Psychiatry 2004, 13(5):428-431.
16. France R.D., Krishnan K.R., Trainor M. Chronic pain and depression. III. Family history study of depression and alcoholism in chronic low back pain patients. Pain 1986, 24(2):185-190.
17. Beekman A.T., Deeg D.J., van Tilberg T., et al. Major and minor depression in later life: a study of prevalence and risk factors. J Affect Disord 1995, 36:65-75.
18. Kendler K.S., Karkowski L.M., Prescott C.A. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 1999, 156:837-841.
19. Sullivan P.F., Neale M.C., Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000, 157:1552-1562.
20. Lopez-Leon S., Janssens A., González-Zuloeta Ladd A.M., et al. Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 2008, 13:772-785.
21. Alexopoulos G.S., Buckwalter K., Olin J., et al. Comorbidity of late life depression: an opportunity for research on mechanisms and treatment. Biol Psychiatry 2002, 52(6):543-558.
22. Otte C., McCaffery J., Ali S., et al. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psychiatry 2007, 164(9):1379-1384.
23. Miller G.E., Chen E., Fok A.K., et al. Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc Natl Acad Sci U S A 2009, 106(34):14716-14721.
24. Checkley S. The neuroendocrinology of depression and chronic stress. Br Med Bull 1996, 52(3):597-617.
25. Teasdale J.D. Emotional processing, three modes of mind and the prevention of relapse in depression. Behav Res Ther 1999, 37(Suppl 1):S53-S77.
26. Husky M.M., Mazure C.M., Paliwal P., et al. Gender differences in the comorbidity of smoking behavior and major depression. Drug Alcohol Depend 2008, 93(1-2):176-179.
27. Wolfe B., Havemen R., Ginther D., et al. The 'window problem' in studies of children's attainments. J Am Stat Assoc 1996, 91:970-982.
28. Moffitt T.E., Caspi A., Rutter M. Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry 2005, 62(5):473-481.
29. Shanahan M.J., Erickson L.D., Vaisey S., et al. Helping relationships and genetic propensities: a combinatoric study of DRD2, mentoring, and educational continuation. Twin Res Hum Genet 2007, 10(2):285-298.
30. Foley D.L., Kendler K.S. A longitudinal study of stressful life events assessed at personal interview with an epidemiologic sample of adult twins: the basis of individual variation in event exposure. Psychol Med 1996, 26:1239-1252.
31. Kendler K.S. Social support: a genetic epidemiologic analysis. Am J Psychiatry 1997, 154:1309-1404.
32. Bergemann C.S., Neiderhiser J.M., Pedersen N.L., et al. Genetic and environmental influences on social support in later life: a longitudinal analysis. Int J Aging Hum Dev 2001, 53:107-135.
33. Plomin R., Lichtenstein P., Pedersen N.L., et al. Genetic influence on life events during the last half of the life span. Psychol Aging 1990, 5:25-30.
34. Wermter A.K., Laucht M., Schimmelmann B.G., et al. From nature versus nurture, via nature and nurture, to gene x environment interaction in mental disorders. Eur Child Adolesc Psychiatry 2010, 19(3):199-210.
35. Hedayati S.S., Bosworth H.B., Kuchibhatla M., et al. The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int 2006, 69(9):1662-1668.
36. Homaifar B.Y., Brenner L.A., Gutierrez P.M., et al. Sensitivity and specificity of the Beck Depression Inventory-II in persons with traumatic brain injury. Arch Phys Med Rehabil 2009, 90(4):652-656.
37. Healey A.K., Kneebone I.I., Carroll M., et al. A preliminary investigation of the reliability and validity of the brief assessment schedule depression cards and the beck depression inventory-fast screen to screen for depression in older stroke survivors. Int J Geriatr Psychiatry 2008, 23(5):531-536.
38. McDonald W.M., Holtzheimer P.E., Haber M., et al. Validity of the 30-item geriatric depression scale in patients with Parkinson's disease. Mov Disord 2006, 21(10):1618-1622.
39. Watson L.C., Lewis C.L., Kistler C.E., et al. Can we trust depression screening instruments in healthy 'old-old' adults?. Int J Geriatr Psychiatry 2004, 19(3):278-285.
40. Henderson N.D., Turri M.G., DeFries J.C., et al. QTL analysis of multiple behavioral measures of anxiety in mice. Behav Genet 2004, 34:267-293.
41. Sturman E.D., Mongrain M. Self-criticism and major depression: an evolutionary perspective. Br J Clin Psychol 2005, 44(4):505-519.
42. Jang K.L., Livesley W.J., Taylor S., et al. Heritability of individual depressive symptoms. J Affect Disord 2004, 80(2-3):125-133.
43. Foley D.L., Neale M.C., Gardner C.O., et al. Major depression and associated impairment: same or different genetic and environmental risk factors?. Am J Psychiatry 2003, 160:2128-2133.
44. Brilman E.I., Ormel J. Life events, difficulties and onset of depressive episodes in later life. Psychol Med 2001, 31:859-869.
45. Moffitt T.E., Caspi A., Taylor A., et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med 2010, 40(6):899-909.
46. Patten S.B. Recall bias and major depression lifetime prevalence. Soc Psychiatry Psychiatr Epidemiol 2003, 38(6):290-296.
47. Green J.G., McLaughlin K.A., Berglund P.A., et al. Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: associations with first onset of DSM-IV disorders. Arch Gen Psychiatry 2010, 67(2):113-123.
48. Drago A., Alboni S., Brunello N., et al. HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory. Eur J Clin Pharmacol 2010, 66(1):5-27.
49. Yonan A.L., Palmer A.A., Gilliam T.C. Hardy-Weinberg disequilibrium identified genotyping error of the serotonin transporter (SLC6A4) promoter polymorphism. Psychiatr Genet 2006, 16(1):31-34.
50. van der Straaten T., van Schaik R.H. Genetic techniques for pharmacogenetic analyses. Curr Pharm Des 2010, 16(2):231-237.
51. Caspi A., Sugden K., Moffitt T.E., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301(5631):368-389.
52. Kendler K.S., Kuhn J.W., Vittum J., et al. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 2005, 62(5):529-535.
53. Uher R., McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry 2008, 13(2):131-146.
54. Caspi A., Hariri A.R., Holmes A., et al. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 2010, 167:509-527.
55. Risch N., Herrell R., Lehner T., et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression. JAMA 2009, 301(23):2462-2471.
56. Jacobs N., Kenis G., Peeters F., et al. Stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression. Arch Gen Psychiatry 2006, 63:989-996.
57. Wichers M., Kenis G., Jacobs N., et al. The BDNF Val(66)Met x 5-HTTLPR x child adversity interaction and depressive symptoms: an attempt at replication. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:120-123.
58. Kumsta R., Stevens S., Brookes K., et al. HTT genotype moderates the influence of early institutional deprivation on emotional problems in adolescence: evidence from the English and Romanian Adoptee (ERA) study. J Child Psychol Psychiatry 2010, 51(7):755-762.
59. Sugden K., Arseneault L., Harrington H., et al. Serotonin transporter gene moderates the development of emotional problems among children following bullying victimization. J Am Acad Child Adolesc Psychiatry 2010, 49(8):830-840.
60. Aslund C., Leppert J., Comasco E., et al. Impact of the interaction between the 5HTTLPR polymorphism and maltreatment on adolescent depression. A population-based study. Behav Genet 2009, 39(5):524-531.
61. Wilhelm K., Mitchell P.B., Niven H., et al. Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry 2006, 188(3):210-215.
62. Cervilla J.A., Rivera M., Molina E., et al. The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: the PREDICT-gene study. Am J Med Genet B Neuropsychiatr Genet 2007, 141(8):912-917.
63. Araya R., Hu X., Heron J., et al. Effects of stressful life events, maternal depression and 5-HTTLPR genotype on emotional symptoms in pre-adolescent children. Am J Med Genet B Neuropsychiatr Genet 2009, 150B(5):670-682.
64. Coventry W.L., James M.R., Eaves L.J., et al. Do 5HTTLPR and stress interact in risk for depression and suicidality? Item response analyses of a large sample. Am J Med Genet B Neuropsychiatr Genet 2010, 153B(3):757-765.
65. Chorbov V.M., Lobos E.A., Todorov A.A., et al. Relationship of 5-HTTLPR genotypes and depression risk in the presence of trauma in a female twin sample. Am J Med Genet B Neuropsychiatr Genet 2007, 144B(6):830-833.
66. Munafo M.R., Flint J. Replication and heterogeneity in gene x environment interaction studies. Int J Neuropsychopharmacol 2009, 12(6):727-729.
67. Kaufman J., Yang B.Z., Douglas-Palumberi H., et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A 2004, 101:17316-17321.
68. Kaufman J., Yang B.Z., Douglas-Palumberi H., et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 2006, 59:673-680.
69. Aguilera M., Arias B., Wichers M., et al. Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population. Psychol Med 2009, 39(9):1425-1432.
70. Ressler K.J., Bradley B., Mercer K.B., et al. Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms. Am J Med Genet B Neuropsychiatr Genet 2010, 153B(3):812-824.
71. Cicchetti D., Rogosch F.A., Sturge-Apple M.L. Interactions of child maltreatment and serotonin transporter and monoamine oxidase A polymorphisms: depressive symptomatology among adolescents from low socioeconomic status backgrounds. Dev Psychopathol 2007, 19(4):1161-1180.
72. Brummett B.H., Boyle S.H., Siegler I.C., et al. Effects of environmental stress and gender on associations among symptoms of depression and the serotonin transporter gene linked polymorphic region (5-HTTLPR). Behav Genet 2008, 38(1):34-43.
73. Lotrich F.E., Pollock B.G., Kirshner M., et al. Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response. J Psychiatry Neurosci 2008, 33(12):123-130.
74. Kim J.M., Stewart R., Kim S.W., et al. Modification by two genes of associations between general somatic health and incident depressive syndrome in older people. Psychosom Med 2009, 71(3):286-291.
75. Grabe H.J., Lange M., Wolff B., et al. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry 2005, 10(2):220-224.
76. Mossner R., Henneberg A., Schmitt A., et al. Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease. Mol Psychiatry 2001, 6(3):350-352.
77. Nakatani D., Sato H., Sakata Y., et al. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 2005, 150(4):652-658.
78. Leifheit-Limson E.C., Reid K.J., Kasl S.V., et al. The role of social support in health status and depressive symptoms after acute myocardial infarction: evidence for a stronger relationship among women. Circ Cardiovasc Qual Outcomes 2010, 3(2):143-150.
79. Ramasubbu R., Tobias R., Buchan A., et al. Serotonin transporter gene promoter region polymorphism associated with poststroke depression. J Neuropsychiatry Clin Neurosci 2006, 18:96-99.
80. Kohen R., Cain K.C., Mitchell P.H., et al. Association of serotonin transporter gene polymorphisms with poststroke depression. Arch Gen Psychiatry 2008, 65(11):1296-1302.
81. McCaffery J.M., Duan Q.L., Frasure-Smith N., et al. Genetic predictors of depressive symptoms in cardiac patients. Am J Med Genet B Neuropsychiatr Genet 2009, 150B(3):381-388.
82. Phillips-Bute B., Mathew J.P., Blumenthal J.A., et al. Relationship of genetic variability and depressive symptoms to adverse events after coronary artery bypass graft surgery. Psychosom Med 2008, 70(9):953-959.
83. Whyte E.M., Pollock B.G., Wagner W.R., et al. Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression. Am J Psychiatry 2001, 158(12):2074-2076.
84. Thomas A.J., Kalaria R.N., O'Brien J.T. Depression and vascular disease: what is the relationship?. J Affect Disord 2004, 79(1-3):81-95.
85. McCaffery J.M., Frasure-Smith N., Dube M.-P., et al. Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med 2006, 68(2):187-200.
86. Lotrich F.E., Ferrell R.E., Rabinovitz M., et al. Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism. Biol Psychiatry 2009, 65(4):344-348.
87. Bull S.J., Huezo-Diaz P., Binder E.B., et al. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-a and ribavirin treatment. Mol Psychiatry 2008, 14:1095-1104.
88. Kraus M.R., Al-Taie O., Schefer A., et al. Serotonin-1A receptor gene (HTR1A) variation predicts interferon-induced depression chronic hepatitis C. Gastroenterology 2007, 132(4):1279-1286.
89. Su K.P., Huang S.Y., Peng C.Y., et al. Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-a-induced depression by regulating polyunsaturated fatty acids levels. Biol Psychiatry 2010, 67:550-557.
90. Musselman D.L., Miller A.H., Porter M.R., et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001, 158(8):1252-1257.
91. Morikawa O., Sakai N., Obara H., et al. Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter. Eur J Pharmacol 1998, 349:317-324.
92. Mossner R., Daniel S., Schmitt A., et al. Modulation of serotonin transporter function by interleukin-4. Life Sci 2001, 68:873-880.
93. Surtees P.G., Wainwright N.W., Willis-Owen S.A., et al. Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder. Biol Psychiatry 2006, 59:224-229.
94. Kim J.M., Stewart R., Kim S.W., et al. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry 2007, 62:423-428.
95. Goldman N., Glei D.A., Lin Y.H., et al. The serotonin transporter polymorphism (5-HTTLPR): allelic variation and links with depressive symptoms. Depress Anxiety 2010, 27(3):260-269.
96. Steffens D.C., Taylor W.D., McQuoid D.R., et al. Short/long heterozygotes at 5HTTLPR and white matter lesions in geriatric depression. Int J Geriatr Psychiatry 2008, 23(3):244-248.
97. Alexopoulos G.S., Murphy C.F., Gunning-Dixon F.M., et al. Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression. J Affect Disord 2009, 119(1-3):132-141.
98. Frodl T., Reinhold E., Koutsouleris N., et al. Childhood stress, serotonin transporter gene and brain structures in major depression. Neuropsychopharmacology 2010, 35(6):1383-1390.
99. Taylor W.D., Steffens D.C., Payne M.E., et al. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression. Arch Gen Psychiatry 2005, 62(5):537-544.
100. Hariri A.R., Drabant E.M., Munoz K.E., et al. A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 2005, 62:146-152.
101. Friedel E., Schlagenhauf F., Sterzer P., et al. 5-HTT genotype effect on prefrontal-amygdala coupling differs between major depression and controls. Psychopharmacology 2009, 205(2):261-271.
102. Pezawas L., Meyer-Lindenberg A., Drabant E.M., et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005, 8:828-834.
103. Brummett B.H., Krystal A.D., Ashley-Koch A., et al. Sleep quality varies as a function of 5-HTTLPR genotype and stress. Psychosom Med 2008, 69:621-624.
104. Alexander N., Kuepper Y., Schmitz A., et al. Gene-environment interactions predict cortisol responses after acute stress: implications for the etiology of depression. Psychoneuroendocrinology 2009, 34(9):1294-1303.
105. Mueller A., Brocke B., Fries E., et al. The role of the serotonin transporter polymorphism for the endocrine stress response in newborns. Psychoneuroendocrinology 2010, 35(2):289-296.
106. Pariante C.M., Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001, 49(5):391-404.
107. Pace T.W., Hu F., Miller A.H. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 2007, 21(1):9-19.
108. Miller G.E., Cohen S., Ritchey A.K. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol 2002, 21:531-541.
109. de Kloet E.R., Derijk R.H., Meijer O.C. Therapy insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression?. Nat Clin Pract Endocrinol Metab 2007, 3(2):168-179.
110. Derijk R.H., de Kloet E.R. Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. Eur J Pharmacol 2008, 583(2-3):303-311.
111. Bet P.M., Penninx B.W., Bochdanovits Z., et al. Glucocorticoid receptor gene polymorphisms and childhood adversity are associated with depression: New evidence for a gene-environment interaction. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:660-669.
112. Tyrka A.R., Price L.H., Gelernter J., et al. Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity. Biol Psychiatry 2009, 66(7):681-685.
113. Bradley R.G., Binder E.B., Epstein M.P., et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 2008, 65(2):190-200.
114. Polanczyk G., Caspi A., Williams B., et al. Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension. Arch Gen Psychiatry 2009, 66(9):978-985.
115. Glatz K., Mossner R., Heils A., et al. Glucocorticoid-regulated human serotonin transporter (5-HTT) expression is modulated by the 5-HTT gene-promoter-linked polymorphic region. J Neurochem 2003, 86:1072-1078.
116. Binder E.B. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009, 34(Suppl 1):S186-S195.
117. Binder E.B., Salyakina D., Lichtner P., et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 2004, 36(12):1319-1325.
118. Gillespie C.F., Phifer J., Bradley K., et al. Risk and resilience: genetic and environmental influences on development of the stress response. Depress Anxiety 2009, 26:984-992.
119. Claes S., Villafuerte S., Forsgren T., et al. The corticotropin-releasing hormone binding protein is associated with major depression in a population from Northern Sweden. Biol Psychiatry 2003, 54(9):867-872.
120. Villafuerte S.M., Del-Favero J., Adolfsson R., et al. Gene-based SNP genetic association study of the corticotropin-releasing hormone receptor-2 (CRHR2) in major depression. Am J Med Genet 2002, 114(2):222-226.
121. Hwang J.P., Tsai S.J., Hong C.J., et al. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging 2005, 27(12):1834-1837.
122. Roth T.L., Lubin F.D., Funk A.J., et al. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 2009, 65(9):760-769.
123. Mossner R., Daniel S., Albert D., et al. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int 2000, 36:197-202.
124. Schule C., Zill P., Baghai T.C., et al. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients. Psychoneuroendocrinology 2006, 31(8):1019-1025.
125. Lin E., Hong C.J., Hwang J.P., et al. Gene-gene interactions of the brain-derived neurotrophic-factor and neurotrophic tyrosine kinase receptor 2 genes in geriatric depression. Rejuvenation Res 2009, 12(6):387-393.
126. Perroud N., Aitchison K.J., Uher R., et al. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology 2009, 34(12):2517-2528.
127. Drachmann B.J., Bock C., Vinberg M., et al. Interaction between genetic polymorphisms and stressful life events in first episode depression. J Affect Disord 2009, 119(1-3):107-115.
128. Gatt J.M., Nemeroff C.B., Dobson-Stone C., et al. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 2009, 14(7):681-695.
129. Golimbet V., Alfimova M., Korovaitseva G., et al. Emotional distress in parents of psychotic patients is modified by serotonin transporter gene (5-HTTLPR)-brain-derived neurotrophic factor gene interactions. Span J Psychol 2009, 12(2):696-706.
130. Conway C., Hammen C., Brennan P.A., et al. Interaction of chronic stress with serotonin transporter and catechol-O-methyltransferase polymorphisms in predicting youth depression. Depress Anxiety 2010, 27(8):737-745.
131. Doornbos B., Dijck-Brouwer D.A., Kema I.P., et al. The development of peripartum depressive symptoms is associated with gene polymorphisms of MAOA, 5-HTT and COMT. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33(7):1250-1254.
132. Chipman P., Jorm A.F., Tan X.Y., et al. No association between the serotonin-1A receptor gene single nucleotide polymorphism rs6295C/G and symptoms of anxiety or depression, and no interaction between the polymorphism and environmental stressors of childhood anxiety or recent stressful life events on anxiety or depression. Psychiatr Genet 2010, 20(1):8-13.
133. Neumeister A., Young T.L., Stastny J. Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter. Psychopharmacology (Berl) 2004, 174:512-524.
134. Jokela M., Lehtimaki T., Keltikangas-Jarvinen L. The influence of urban/rural residency on depressive symptoms is moderated by the serotonin receptor 2A gene. Am J Med Genet B Neuropsychiatr Genet 2007, 144B(7):918-922.
135. Gatt J.M., Williams L.M., Schofield P.R., et al. Impact of the HTR3A gene with early life trauma on emotional brain networks and depressed mood. Depress Anxiety 2010, 27(8):752-759.
136. Xu Y., Li F., Huang X., et al. The norepinephrine transporter gene modulates the relationship between urban/rural residency and major depressive disorder in a Chinese population. Psychiatry Res 2009, 168(3):213-217.
137. Oxenkrug G.F. Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism. Ann N Y Acad Sci 2010, 1199:1-14.
138. Gabbay V., Klein R.G., Katz Y., et al. The possible role of the kynurenine pathway in adolescent depression with melancholic features. J Child Psychol Psychiatry 2010, 51(8):935-943.
139. Wichers M.C., Maes M. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. J Psychiatry Neurosci 2004, 29(1):11-17.
140. Markus C.R., Firk C. Differential effects of tri-allelic 5-HTTLPR polymorphisms in healthy subjects on mood and stress performance after tryptophan challenge. Neuropsychopharmacology 2009, 34(13):2667-2674.
141. Walderhaug E., Magnusson A., Neumeister A., et al. Interactive effects of sex and 5-HTTLPR on mood and impulsivity during tryptophan depletion in healthy people. Biol Psychiatry 2007, 62(6):593-599.
142. Neumeister A., Konstantinidis A., Stastny J., et al. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 2002, 59(7):613-620.
143. Jokela M., Raikkonen K., Lehtimak I.T., et al. Tryptophan hydroxylase 1 gene (TPH1) moderates the influence of social support on depressive symptoms in adults. J Affect Disord 2007, 100(1-3):191-197.
144. Keltikangas-Jarvinen L., Puttonen S., Kivimaki M.E., et al. Tryptophan hydroxylase 1 gene haplotypes modify the effect of a hostile childhood environment on adulthood harm avoidance. Genes Brain Behav 2007, 6:305-313.
145. Nobile M., Ruscon I.M., Bellina M., et al. The influence of family structure, the TPH2 G-703T and the 5-HTTLPR serotonergic genes upon affective problems in children aged 10-14 years. J Child Psychol Psychiatry 2009, 50(3):317-325.
146. Comings D.E., Muhleman D., Dietz G., et al. Sequence of human tryptophan 2,3-dioxygenase (TDO2): presence of a glucocorticoid response-like element composed of a GTT repeat and an intronic CCCCT repeat. Genomics 1995, 29:390-396.
147. Kravitz M., Janssen I., Lotrich F.E., et al. Sex steroid hormone gene polymorphisms and depressive symptoms. Am J Med 2006, 119(Suppl 1):87-93.
148. Cole S.W., Arevalo J.M., Takahashi R., et al. Computational identification of gene-social environment interaction at the human IL6 locus. Proc Natl Acad Sci U S A 2010, 107(12):5681-5686.
149. Traykov L., Bayle A., Latour F., et al. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease. J Neurol Sci 2007, 257(1-2):280-283.
150. Sjoholm L.K., Melas P.A., Forsell Y., et al. PreproNPY Pro7 protects against depression despite exposure to environmental risk factors. J Affect Disord 2009, 118(1-3):124-130.
151. Juhasz G., Chase D., Pegg E., et al. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms. Neuropsychopharmacology 2009, 34(8):2019-2027.
152. Wong M.L., Dong C., Maestre-Mesa J., et al. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry 2008, 13(8):800-812.
153. Chen P., Jiang T., Ouyang J., et al. Epigenetic programming of diverse glucocorticoid response and inflammatory/immune-mediated disease. Med Hypotheses 2009, 73(5):657-658.
154. Tsankova N.M., Berton O., Renthal W., et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006, 9(4):519-525.
155. Weaver I.C., Cervoni N., Champagne F.A., et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004, 7:847-853.
156. McGowan P.O., Sasaki A., D'Alessio A.C., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009, 12(3):342-348.
157. Keller S., Sarchiapone M., Zarrilli F., et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry 2010, 67(3):258-267.
158. Alt S.R., Turner J.D., Klok M.D., et al. Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed. Psychoneuroendocrinology 2010, 35(4):544-556.
159. Philibert R., Madan A., Andersen A., et al. Serotonin transporter mRNA levels are associated with the methylation of an upstream CpG island. Am J Med Genet B Neuropsychiatr Genet 2007, 114B(1):101-105.
160. Philibert R.A., Sandhu H., Hollenbeck N., et al. The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. Am J Med Genet B Neuropsychiatr Genet 2008, 150B(1):153.
161. Olsson C.A., Foley D.L., Parkinson-Bates M., et al. Prospects for epigenetic research within cohort studies of psychological disorder: a pilot investigation of a peripheral cell marker of epigenetic risk for depression. Biol Psychol 2010, 83(2):159-165.
162. Kendler K.S., Kuhn J., Prescott C.A. The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression. Am J Psychiatry 2004, 161:631-636.